Analysis of the Influence of Hormone Replacement Therapy on Osteocalcin Gene Expression in Postmenopausal Women

Table 1

Information about patients enrolled for the study.

Research group	Sample number	Age; years; (M ± SD)	Control group	Sample number	Age; years; (M ± SD)	Statistically significant differences between results in control and research group ( < 0.05)
M + HRT	15	53,27 ± 3,13	M	15	55,20 ± 2,21	No
OV + HRT	15	52,73 ± 2,81	OV	15	55,60 ± 2,10	No
		Time from last menstrual period; months; (M ± SD)			Time from last menstrual period; months; (M ± SD)
M + HRT	15	43,3 ± 3,8	M	15	41,5 ± 3,9	No
OV + HRT	15	41,5 ± 5,1	OV	15	42,7 ± 4,1	No
		Duration of HRT; months; (M ± SD)			Duration of HRT; months; (M ± SD)
M + HRT	15	17,0 ± 3,8	M	15	17,6 ± 3,6	No
OV + HRT	15	17,6 ± 4,1	OV	15	16,8 ± 3,5	No
		Body mass index; (M ± SD)			Body mass index; (M ± SD)
M + HRT	15	27,73 ± 0,70	M	15	27,87 ± 0,83	No
OV + HRT	15	27,87 ± 0,83	OV	15	27,80 ± 0,77	No